|
In a short span of 10 years, nucleic acid based therapeutics has moved from concept
to clinic, and rapid progress in this field is ongoing. AAPS provides an excellent
forum to bring the concept of nucleic acid based therapeutics therapy to the mainstream.
The mission of the focus group is to update the pharmaceutical community on the
progress of nucleic acid-based therapies including antisense technologies, and to
provide a forum to generate discussion on current issues involved in developing
effective clinical nucleic acid-based products. This includes clinical trial updates,
emerging technologies relating to delivery and expression of genes/oligonucleotides
to target tissues, FDA regulations, manufacture/scale-up, and formulations.
LINKS
Back To Top
REFERENCES
M.E. Kleinman, K. Yamada, A Takeda et.al. "Sequence – and target-independent angiogenesis suppression by siRNA
via TLR3" Nature 2008, April; 452 (7187):591-597 available through
NIH Public Access (PMC 2009 February 15)
Back To Top
JOIN THE NUCLEIC ACID BASED THERAPEUTICS FOCUS GROUP
To join the Nucleic Acid Based Therapeutics Focus Group, click
here.
Back To Top
|
